XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$7.89
Tradestie Score
50
Market Cap
$241.60M
Revenue Growth
0.2%
Analyst Upside
+28.6%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$17.78
|
$1.13B | - | 33 | Compare |
|
CDNA
CareDx, Inc.
|
$66.23
|
$798.40M | 30.8 | 32 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.30
|
$719.31M | - | 48 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$35.26
|
$667.77M | - | 43 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.17
|
$612.76M | - | 62 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.68
|
$504.67M | - | 46 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$2.50
|
$81.31M | - | 43 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$27.33
|
$61.36M | - | 38 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$1.25
|
$59.42M | - | 38 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$4.52
|
$41.94M | - | 66 | Compare |
More XGN Analysis
Data updated: Oct 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry